O-015 Association between depth of response (DpR) and survival outcomes in RAS-wild-type (wt) patients with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab once-every-2-weeks in the APEC study
Titel:
O-015 Association between depth of response (DpR) and survival outcomes in RAS-wild-type (wt) patients with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab once-every-2-weeks in the APEC study
Auteur:
Cheng, A.-L. Cornelio, G. Shen, L. Price, T. Yang, T.-S. Chung, I.-J. Dai, G.-H. Lin, J.-K. Sharma, A. Yeh, K.-H. Ma, B. Zaatar, A. Guan, Z.-Z. Masood, N. Srimuninnimit, V. Yau, T. Beier, F. Chatterjee, S. Lim, R.